Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 3Withdrawn 1

Sponsor Class

OTHER 3

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

Genitourinary 1Gastrointestinal 1

Conditions

Polycystic Ovary Syndrome 5Insulin Resistance 3Diabetes Mellitus, Type 2 3Urinary Bladder Neoplasms 2Pancreatic Neoplasms 2Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2Diabetes Mellitus 2Carotid Intimal Medial Thickness 1 2Thyroid Cancers That Contain the PAX8-PPARgamma Fusion Gene 1Skin Neoplasms 1Prostatic Neoplasms 1Pharmacokinetics of MDV3100 1Neoplasms 1Neoplasm Metastasis 1Meningioma 1Memory Disorders 1Liposarcoma, Myxoid 1Liposarcoma 1Leukoplakia, Oral 1Leukemia, Myeloid, Chronic-Phase 1Inflammation 1Head and Neck Neoplasms 1Glioblastoma 1Cognitive Dysfunction 1Carcinoma, Squamous Cell 1Brain Neoplasms 1Astrocytoma 1

Interventions

relacorilant 4Resistance Training 3Pioglitazone 3Dipeptidyl-Peptidase IV Inhibitors 3Sulfonylurea Compounds 2Rosiglitazone 2Nutritional Status 2Metformin 2voglibose 1saxagliptin 1repaglinide 1pembrolizumab 1miglitol 1metahexamide 1meglitinide 1glymidine 1glisoxepide 1gliquidone 1glimepiride 1glibornuride 1empagliflozin 1Vildagliptin 1Troglitazone 1Tolbutamide 1Tolazamide 1Thiazolidinediones 1Surveys and Questionnaires 1Sodium-Glucose Transporter 2 Inhibitors 1Sitagliptin Phosphate 1Resistant Starch 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Diabetes Mellitus, Type 2 × Pioglitazone × Clear all
NCT01935466 2022-01-25

PROBE-PIO

Post Graduate Institute of Medical Education and Research, Chandigarh

Completed
6,107 enrolled
Genitourinary

Urinary Bladder Neoplasms, Diabetes Mellitus, Type 2

NCT02475499 2016-03-14

Incretin-based Drugs and Pancreatic Cancer

Canadian Network for Observational Drug Effect Studies, CNODES

Completed
886,172 enrolled
Gastrointestinal

Diabetes Mellitus, Type 2, Pancreatic Neoplasms

NCT01223196 2016-01-11

PIO-TACE

The University of Texas Health Science Center at San Antonio

Phase 4 Completed
60 enrolled 8 charts

Diabetes Mellitus, Type 2, Insulin Resistance

Data powered by HemOnc (CC BY 4.0) Colophon âš¡